Cargando…

Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis

Detalles Bibliográficos
Autores principales: Ameye, Heleen, Fransis, Sabine, Lerut, Evelyne, Metalidis, Christoph, Sprangers, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678843/
https://www.ncbi.nlm.nih.gov/pubmed/29142922
http://dx.doi.org/10.1016/j.ekir.2016.06.004
_version_ 1783277522738216960
author Ameye, Heleen
Fransis, Sabine
Lerut, Evelyne
Metalidis, Christoph
Sprangers, Ben
author_facet Ameye, Heleen
Fransis, Sabine
Lerut, Evelyne
Metalidis, Christoph
Sprangers, Ben
author_sort Ameye, Heleen
collection PubMed
description
format Online
Article
Text
id pubmed-5678843
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56788432017-11-15 Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis Ameye, Heleen Fransis, Sabine Lerut, Evelyne Metalidis, Christoph Sprangers, Ben Kidney Int Rep Nephrology Round Elsevier 2016-06-29 /pmc/articles/PMC5678843/ /pubmed/29142922 http://dx.doi.org/10.1016/j.ekir.2016.06.004 Text en © 2016 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Nephrology Round
Ameye, Heleen
Fransis, Sabine
Lerut, Evelyne
Metalidis, Christoph
Sprangers, Ben
Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
title Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
title_full Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
title_fullStr Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
title_full_unstemmed Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
title_short Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
title_sort beneficial effect of rituximab in the treatment of esophageal cancer–associated pauci-immune glomerulonephritis
topic Nephrology Round
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678843/
https://www.ncbi.nlm.nih.gov/pubmed/29142922
http://dx.doi.org/10.1016/j.ekir.2016.06.004
work_keys_str_mv AT ameyeheleen beneficialeffectofrituximabinthetreatmentofesophagealcancerassociatedpauciimmuneglomerulonephritis
AT fransissabine beneficialeffectofrituximabinthetreatmentofesophagealcancerassociatedpauciimmuneglomerulonephritis
AT lerutevelyne beneficialeffectofrituximabinthetreatmentofesophagealcancerassociatedpauciimmuneglomerulonephritis
AT metalidischristoph beneficialeffectofrituximabinthetreatmentofesophagealcancerassociatedpauciimmuneglomerulonephritis
AT sprangersben beneficialeffectofrituximabinthetreatmentofesophagealcancerassociatedpauciimmuneglomerulonephritis